Literature DB >> 4381645

Which hypotensive drug?

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4381645      PMCID: PMC1842108     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION.

Authors:  M HAMILTON; E M THOMPSON; T K WISNIEWSKI
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  A comparison of the effects of phenobarbitone and reserpine in hypertension.

Authors:  E H COOPER; W I CRANSTON
Journal:  Lancet       Date:  1957-02-23       Impact factor: 79.321

3.  Incidence of a positive direct coombs test in patients on alpha-methyldopa.

Authors:  K C Carstairs; A Breckenridge; C T Dollery; S M Worlledge
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

4.  Combined action of methyldopa and bethanidine. Evidence for a synergistic effect.

Authors:  A Breckenridge; C T Dollery
Journal:  Lancet       Date:  1966-05-14       Impact factor: 79.321

5.  The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.

Authors:  J A Oates; A W Seligmann; M A Clark; P Rousseau; R E Lee
Journal:  N Engl J Med       Date:  1965-09-30       Impact factor: 91.245

6.  Treatment of hypertension with methyldopa.

Authors:  P Johnson; A H Kitchin; C P Lowther; R W Turner
Journal:  Br Med J       Date:  1966-01-15

7.  Comparison of mebutamate, phenobarbital, and placebo in the treatment of mild essential hypertension.

Authors:  E J Chesrow; M Bernstein; D Weiss; G H Marquardt
Journal:  Am J Med Sci       Date:  1966-02       Impact factor: 2.378

8.  Experience with guanoxan in the treatment of hypertension.

Authors:  S G Sheps; P J Osmundson; J F Fairbairn; A Schirger; G J Kavanaugh; M K Burbank
Journal:  Mayo Clin Proc       Date:  1966-09       Impact factor: 7.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.